Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
10,924
Total Claims
$842K
Drug Cost
685
Beneficiaries
$1,229
Cost/Patient
Risk Score Breakdown 9/100
Score components are additive. Read full methodology
Peer Comparison vs. 110,156 Internal Medicine providers
-53%
Opioid rate vs peers
1.1% vs 2.2% avg
-13%
Cost per patient vs peers
$1,229 vs $1,411 avg
+3%
Brand preference vs peers
11.0% vs 10.6% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
1.1%
Opioid Rate
116
Opioid Claims
$1,398
Opioid Cost
—
Long-Acting Rate
Brand vs Generic
Brand: 1,182 claims · $650K
Generic: 9,594 claims · $178K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 62 | $75K |
| Insulin Glargine,hum.Rec.Anlog | 69 | $57K |
| Sitagliptin Phosphate | 39 | $53K |
| Apixaban | 35 | $52K |
| Insulin Glargine,hum.Rec.Anlog | 80 | $38K |
| Semaglutide | 27 | $27K |
| Fluticasone Propion/Salmeterol | 108 | $26K |
| Insulin Nph Hum/Reg Insulin Hm | 46 | $23K |
| Insulin Glargine,hum.Rec.Anlog | 40 | $20K |
| Fluticasone/Umeclidin/Vilanter | 22 | $19K |
| Empagliflozin | 12 | $19K |
| Linaclotide | 17 | $19K |
| Rosuvastatin Calcium | 693 | $15K |
| Fluticasone Propion/Salmeterol | 18 | $12K |
| Insulin Nph Hum/Reg Insulin Hm | 14 | $11K |
Prescribing Profile
Patient Profile
71
Avg Age
52%
Female
2.21
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data